Category Archives: MS Treatment

The only curative approach to treating myelofibrosis (MF) at this time is hematopoietic stem cell transplant, but the treatment landscape for this patient population continues to expand, particularly since the identification of the JAK-STAT pathway as a potential target in 2005. Although the introduction of novel agents like JAK inhibitors have been promising for the treatment of patients with MF, there are more agents coming down the pipeline as well that will impact the way physicians treat this population.1 During the National Comprehensive Cancer Network (NCCN) 2020 Virtual Congress: Hematologic Malignancies, Aaron Gerds, MD, MS, assistant professor of medicine (hematology and medical oncology), Cleveland Clinic Taussig Cancer Institute, reviewed the current treatment landscape for patients with MF and whats to come for the treatment of this patient population as clinical trials continue to advance the field. Treatments of MF focus on the symptoms of the disease. Continue reading →

By:Linda White-Francis We used to sit on my big front porch and talk. The summers were long and boring and there wasnt much to do, so wed amuse ourselves with Monopoly or Clue. Continue reading →

The innovation experts at Cleveland Clinic have peered into their crystal ball and pronounced the most profound medical advancements that will impact the care and treatment of patients in the coming year. During the closing session of the 2020 Cleveland Clinic Medical Innovation Summit, the 18th year the conference has been held, Cleveland Clinic Innovations shared its annual list of top 10 medical innovations Continue reading →

Cleveland Clinic released its list of the top 10 medical innovations it believes will change health care next year, including gene therapy for blood disorders, a new class of medications for cystic fibrosis and increased access to telemedicine, according to a news release. The annual list, which is selected by a panel of Clinic researchers and clinicians, was announced in conjunction with the system's 18th annual Medical Innovation Summit, which was held virtually on Tuesday, Oct. Continue reading →

October 9, 2020 | MITs preprint reviewers debunk synthetic SARS-CoV-2 paper, genetic analysis of virus samples show most COVID-19 cases in Southern California early in the pandemic are linked to New York state via Europe, not directly from China, vaccines should not be affected by the dominant G-strain, severe cases of COVID-19 develop a novel T cell subset that can potentially kill B cells, and MS drug inhibits virus growth. Plus, NIH funds COVID-10 vaccine using bovine adenovirus. Continue reading →

The white blood cell TH17 helps the immune system fight infection by promoting inflammation. Continue reading →

Isaac Saunders-Rennards may need to travel to Germany for proton beam therapy THE family of a three-year-old boy have been told they must raise 70,000 to pay for his cancer treatment. Continue reading →

Since emigrating from Syria at the age of five, I have personally experienced the uphill battle of obtaining health care coverage as a non-US citizen. My family, along with many other immigrant and low-income families, are often forced to choose between receiving care and prescription medicines or paying a stream of medical bills Continue reading →

Newswise October 5, 2020(BRONX, N.Y) Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert Einstein College of Medicine and Montefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimers disease. Continue reading →

Gilenya (fingolimod) and Tecfidera (dimethyl fumarate) are similarly effective at lowering the frequency of relapses and delaying disability progression in people with relapsing-remitting multiple sclerosis (RRMS), a real-world study from Switzerland reported. Continue reading →